These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 388793)

  • 1. Immunologic testing of patients with genitourinary malignancies.
    Lange PH
    Urol Clin North Am; 1979 Oct; 6(3):587-97. PubMed ID: 388793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Significance of tumor markers in the treatment of urological malignancies].
    Akaza H; Kameyama S; Aso Y
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3034-40. PubMed ID: 2445294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A B O (H) blood group antigen determination in genitourinary neoplasms.
    Ghazizadeh M; Kagawa S
    Tokushima J Exp Med; 1983 Jun; 30(1-2):9-16. PubMed ID: 6685361
    [No Abstract]   [Full Text] [Related]  

  • 4. [Metastasis and markers].
    Trinchieri A; Rovera F; Longo G; Del Nero A; Zanetti G; Austoni E
    Arch Ital Urol Nefrol Androl; 1992 Mar; 64(1):27-30. PubMed ID: 1373913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [PPD, PHA and Su-PS skin tests in genitourinary malignancies].
    Amano T; Koshida K; Nakajima K; Naito K; Hisazumi H
    Hinyokika Kiyo; 1985 Dec; 31(12):2107-11. PubMed ID: 3914213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical cancer advances 2006: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
    Ozols RF; Herbst RS; Colson YL; Gralow J; Bonner J; Curran WJ; Eisenberg BL; Ganz PA; Kramer BS; Kris MG; Markman M; Mayer RJ; Raghavan D; Reaman GH; Sawaya R; Schilsky RL; Schuchter LM; Sweetenham JW; Vahdat LT; Winn RJ;
    J Clin Oncol; 2007 Jan; 25(1):146-62. PubMed ID: 17158528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy and prognosis of tumors of the genitourinary tract after kidney transplantation.
    Diller R; Gruber A; Wolters H; Senninger N; Spiegel HU
    Transplant Proc; 2005 Jun; 37(5):2089-92. PubMed ID: 15964347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical evaluation of lymphocyte functions in urological cancer patients.
    Elhilali MM; Paika KD; Brosman S; Fahey JL
    Cancer Res; 1976 Jan; 36(1):132-7. PubMed ID: 1082369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric genitourinary tumors.
    Castellino SM; McLean TW
    Curr Opin Oncol; 2007 May; 19(3):248-53. PubMed ID: 17414644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor markers in urology.
    Grossman HB
    Semin Urol; 1985 Feb; 3(1):10-7. PubMed ID: 2408306
    [No Abstract]   [Full Text] [Related]  

  • 11. Genitourinary malignancies.
    Selman SH
    Prim Care; 1989 Dec; 16(4):1013-30. PubMed ID: 2692040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Early detection of urogenital cancers: kidney, bladder, prostatic and testicular cancers].
    Kawai T; Yamauchi T; Tachibana Y; Yoshino S; Kokuho M
    Gan No Rinsho; 1988 Aug; 34(10):1403-7. PubMed ID: 3172497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunology of the bladder.
    Graham SD
    Urol Clin North Am; 1992 Aug; 19(3):541-8. PubMed ID: 1636238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic resonance imaging in the evaluation of urologic malignancies.
    Demas BE; Hricak H; Williams RD
    Semin Urol; 1985 Feb; 3(1):27-33. PubMed ID: 4001653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunology of genitourinary malignancies.
    deKernion JB
    Proc Inst Med Chic; 1977; 31(5):151-2. PubMed ID: 562517
    [No Abstract]   [Full Text] [Related]  

  • 17. Urinary and tissue levels of scatter factor in transitional cell carcinoma of bladder.
    Rosen EM; Joseph A; Jin L; Yao Y; Chau MH; Fuchs A; Gomella L; Hastings H; Goldberg ID; Weiss GH
    J Urol; 1997 Jan; 157(1):72-8. PubMed ID: 8976219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tube LAI assay in diagnosis and monitoring of a cancer disease.
    Hasek M; Holán V; Kousalová M
    Biomedicine; 1981 Dec; 35(7-8):207-8. PubMed ID: 7049257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of immunosuppressive acid protein in genitourinary malignant diseases].
    Okada S; Kirime S; Kawasaki T; Kanbara A; Kanehara H; Takasaki N; Miyazaki S; Inai S
    Hinyokika Kiyo; 1988 Mar; 34(3):411-8. PubMed ID: 3389287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate cancer-associated markers.
    Chu TM
    Immunol Ser; 1990; 53():339-56. PubMed ID: 1713065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.